Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Natera, Inc.    NTRA

NATERA, INC.

(NTRA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Natera : Announces Pricing of Follow-On Offering

share with twitter share with LinkedIn share with facebook
09/11/2020 | 01:10am EDT
http://nateranewsfeed.mediaroom.com/2020-09-11-Natera-Announces-Pricing-of-Follo...

Disclaimer

Natera Inc. published this content on 10 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2020 05:09:05 UTC


share with twitter share with LinkedIn share with facebook
All news about NATERA, INC.
10/05NATERA : Court Rejects ArcherDX's Motion to Dismiss Natera's Patent Infringement..
PR
09/24NATERA : Medicare Issues Draft Local Coverage Determination for Signatera™..
PR
09/18NATERA : to Present New Gastrointestinal Cancer Data at the ESMO Annual Meeting
PR
09/14NATERA : Launches Initiative to Transform the Management of Cancer Patients in O..
PR
09/11NATERA, INC. : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
09/11NATERA : Signatera™ MRD Test Receives a Final Coverage Decision from Norid..
PR
09/11NATERA : Announces Pricing of Follow-On Offering
PU
09/11NATERA : Announces Pricing of Follow-On Offering
PR
09/10NATERA : to Present at the Morgan Stanley 18th Annual Global Healthcare Conferen..
PR
09/09NATERA : Launches Proposed Follow-On Offering
PR
More news
Financials (USD)
Sales 2020 360 M - -
Net income 2020 -203 M - -
Net cash 2020 341 M - -
P/E ratio 2020 -28,1x
Yield 2020 -
Capitalization 5 975 M 5 975 M -
EV / Sales 2020 15,7x
EV / Sales 2021 13,6x
Nbr of Employees 1 039
Free-Float 95,5%
Chart NATERA, INC.
Duration : Period :
Natera, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATERA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 76,67 $
Last Close Price 71,08 $
Spread / Highest target 26,6%
Spread / Average Target 7,86%
Spread / Lowest Target -15,6%
EPS Revisions
Managers
NameTitle
Stephen Chapman President, Chief Executive Officer & Director
Matthew Rabinowitz Executive Chairman
Robert A. Schueren Chief Operating Officer
Michael Brophy Chief Financial Officer
Jonathan Sheena Director & Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
NATERA, INC.110.98%5 975
BIOMÉRIEUX74.92%19 244
10X GENOMICS, INC.114.69%17 602
DIASORIN S.P.A.68.63%12 383
AUTOBIO DIAGNOSTICS CO., LTD.74.05%10 952
MACCURA BIOTECHNOLOGY CO.LTD105.67%4 694